| P50 | author | Stewart J. Tepper | Q78651257 |
| P2093 | author name string | Jan Lewis Brandes | |
| | David B Kudrow | |
| | Peter C Schmidt | |
| | James Weintraub | |
| | Donald J Kellerman | |
| | Egilius Lh Spierings | |
| P2860 | cites work | EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force | Q28256451 |
| | Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study | Q30965923 |
| | Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials | Q34154647 |
| | Treatment of acute migraine headache. | Q34163270 |
| | Clinical pharmacokinetics of intranasal sumatriptan. | Q34791976 |
| | Non-oral formulations of triptans and their use in acute migraine | Q36133893 |
| | The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies | Q38323922 |
| | Migraine and Drug Absorption | Q39758608 |
| | Zolmitriptan nasal spray: advances in migraine treatment | Q44634132 |
| | Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray | Q47883597 |
| | Comparison of the Efficacy of Zolmitriptan and Sumatriptan: Issues in Migraine Trial Design | Q57024741 |
| | Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial | Q73210041 |
| | Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators | Q95457200 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 215-224 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine | |
| P478 | volume | 38 | |